Concepedia

Anna Kiyomi

AK

Statistics

Publications

11

Citations

176

H-Index

10

Active since

2015

Affiliations

Tokyo University of Pharmacy and Life Sciences(Current)

Chinese Academy of Medical Sciences & Peking Union Medical College

Josai University

Xiyuan Hospital

Beijing University of Chinese Medicine

Anna Kiyomi is an author at Tokyo University of Pharmacy and Life Sciences specializing in oncology, cancer pharmacology, and pharmacology.

Publications per year

2015–2022

11

Publications

11

Chemo-sensitivity of Two-dimensional Monolayer and Three-dimensional Spheroid of Breast Cancer MCF-7 Cells to Daunorubicin, Docetaxel, and Arsenic Disulfide

Nami Uematsu, Yuxue Zhao, Anna Kiyomi et al. · Anticancer Research · 2018 · 23 citations

Medicine, Oncology, Pharmacology +15

Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells

Yu Zhang, Bo Yuan, Baolin Bian et al. · Frontiers in Oncology · 2021 · 23 citations · Full text

Medicine, Oncology, Pharmacology +17

Effects of arsenic disulfide on proliferation, cytokine production, and frequencies of CD4 + , CD8 + , and regulatory T cells in mitogen-activated human peripheral blood mononuclear cells

Minmin Song, Su Fang, Sachiko Tanaka et al. · International Immunopharmacology · 2015 · 21 citations

Life Sciences, Cell Biology, Immunology +16

Salivary inflammatory mediators as biomarkers for oral mucositis and oral mucosal dryness in cancer patients: A pilot study

Anna Kiyomi, Kensuke Yoshida, Chie Arai et al. · PLoS ONE · 2022 · 20 citations · Full text

Dentistry, Immunology, Oncology +15

JNK and Autophagy Independently Contributed to Cytotoxicity of Arsenite combined With Tetrandrine via Modulating Cell Cycle Progression in Human Breast Cancer Cells

Bowen Yu, Bo Yuan, JingZhe Li et al. · Frontiers in Pharmacology · 2020 · 18 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 11